Arteriocyte Medical Systems Announces Strategic Investment in Control Medical Technology.CLEVELAND -- Arteriocyte Medical Systems announced today a strategic investment in Control Medical Technology, a medical device developer based in Park City, Utah Park City is a city located in Summit County, Utah, United States. It is one of two major resort towns in Utah, the other being Moab. It is considered to be part of the Wasatch Back and a part of the Salt Lake City metropolitan area. . The investment will enable development and distribution of Control's ASPIRE handheld disposable aspiration system for use with Arteriocyte Medical's STEM-PREP and other Magellan([R])-platform technologies. The two companies will develop the ASPIRE system for surgical applications including bone marrow aspiration and disc decompression. Arteriocyte Medical Systems will serve as the exclusive U.S. orthopedic distributor for the ASPIRE bone marrow aspiration and disc decompression devices. Arteriocyte Medical's Magellan([R]) device platform provides rapid bedside stem cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. and platelet concentration technology for surgical applications. Arteriocyte Medical recently launched the Magellan STEM-PREP rapid marrow concentration system to allow physicians to harvest and concentrate stem cells stem cells, unspecialized human or animal cells that can produce mature specialized body cells and at the same time replicate themselves. Embryonic stem cells are derived from a blastocyst (the blastula typical of placental mammals; see embryo), which is very young and platelets at bedside using a patient's own marrow for therapeutic use during a surgical procedure. "We are excited to partner with Arteriocyte Medical Systems to develop new applications for the ASPIRE system," said Shawn Fojtik, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Control Medical. "The strategic investment by Arteriocyte Medical will allow us to accelerate the development for the ASPIRE system in important surgical arenas, while leveraging Arteriocyte Medical's well established distribution channels in orthopedics." Arteriocyte's CEO Don Brown said, "Control Medical's FDA-cleared ASPIRE handheld disposable aspiration system represents an important innovation for surgeons needing to aspirate as·pi·rate v. To take in or remove by aspiration. n. A substance removed by aspiration. Aspirate The removal by suction of a fluid from a body cavity using a needle. tissue during surgery. The ASPIRE device provides increased aspiration force, volume and improves tactile feel and feedback for the surgeon while providing single-handed control during the tissue harvesting procedure. We are thrilled to be working with Shawn and team to accelerate our cell and tissue engineering efforts in Utah." About Arteriocyte and Arteriocyte Medical Systems Arteriocyte, is a commercial stage Biotechnology Company with facilities in Cleveland, Ohio "Cleveland" redirects here. For the Cleveland metropolitan area, see . For other uses, see Cleveland (disambiguation). Cleveland is a city in the U.S. state of Ohio and the county seat of Cuyahoga County, the most populous county in the state. , Hopkinton, Massachusetts, and Minneapolis, Minnesota, is developing proprietary stem cell therapies stem cell therapy Cell therapy Molecular medicine A technology in which a person's own cells–eg, neuronal stem cells are triggered to revert to their primitive embryonic form, then redifferentiate into mature cells of various organs for human clinical application. Arteriocyte's goal is to develop commercially available stem cell based therapies using multiple sources of adult derived stem cells (marrow, peripheral, cord blood cord blood n. Blood present in the umbilical vessels at the time of delivery. , and cartilage). Arteriocyte Medical Systems is a leading medical device company committed to developing and marketing novel medical products to improve surgical outcomes. Established in 2007 by Arteriocyte, Inc. and DW Healthcare Partners, Arteriocyte Medical Systems is devoted to providing innovative solutions to patients and medical professionals to address serious unmet medical needs particularly in cardiac, orthopedic and vascular surgeries. Today, the Magellan([R]) platelet and stem cell separation platform is in use in over 400 surgical centers worldwide. About Control Medical Technology and ASPIRE Control Medical Technology, headquartered in Park City, Utah, designs, develops, and markets medical devices to help physicians, nurses, technicians, and other caregivers improve patient care. Its FDA-approved ASPIRE systems are used to remove fluids, tumors, bone, bone marrow, endometrial endometrial /en·do·me·tri·al/ (en?do-me´tre-il) pertaining to the endometrium. endometrial, n relating to the end-ometrium or cavity of the uterus. fluids, blood clots Blood Clots Definition A blood clot is a thickened mass in the blood formed by tiny substances called platelets. Clots form to stop bleeding, such as at the site of cut. , tissue, and other pathology, targeting unmet clinical needs in oncology, orthopedics, spine, pain management and cardiovascular medicine. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion